CPE and hepatocellular carcinoma: Moreover, sEVs secreted by highly metastatic HCC cells carry carboxypeptidase E (CPE), which can be taken up by low-metastatic cells, promoting their malignant transformation, whereas CPE inhibition reverses this effect (55).